First AD

Second AD

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Insights Video Series

Assessing Liver Function in Patients with HCC

Rachna Shroff, MD, MS, FASCO, shares data from the CARES-310 study showing improved progression-free and overall survival in patients with hepatocellular carcinoma treated with camrelizumab and rivoceranib compared to sorafenib, regardless of liver function.

Rivoceranib plus Camrelizumab for First-Line Treatment of HCC: Data from CARES-310

Risk Factors of Hepatocellular Carcinoma (HCC)

Importance of Assessing Liver Function in HCC

Assessing Liver Function in Patients With HCC: The ALBI Score

Assessing Liver Function in Patients With HCC: The Child-Pugh Score

Assessing Liver Function in Patients With HCC: The MELD Score

Updates in First-Line Systemic Therapy for Patients With HCC

Key Outcomes Data in Patients With HCC Based on Liver Function

The Future of Liver Function Assessments in HCC